Overview
Dr. Spurney’s research has focused on the role of G protein coupled receptors (GPCRs) in regulating cellular physiology both in normal and disease states as well as the regulatory mechanisms that modulate GPCR responsiveness at the molecular level. These studies have centered on two major themes. The first investigates the role of GPCR signaling pathways in regulating podocyte function using cultured podocytes and transgenic animals models. The second area of research involves the role of GPCR kinases (GRKs) and arrestin scaffolding proteins in modulating GPCR signaling in bone forming osteoblasts using cultured osteoblast cell lines as well as genetically modified mice including transgenic models and knockout animals. The long-term goal of these studies is to identify novel therapeutic targets that may useful for treating disease processes such as glomerulonephritis and osteoporosis.
Please see the Duke Nephrology Division website for more detailed information.
Please see the Duke Nephrology Division website for more detailed information.
Current Duke Appointments & Affiliations
Professor of Medicine
·
2012 - Present
Medicine, Nephrology,
Medicine
Member of the Duke Cancer Institute
·
1983 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
Podocyte specific knockout (KO) of the natriuretic peptide clearance receptor (NPRC) attenuates diabetic kidney disease (DKD).
Journal article Physiol Rep · May 2026 Glomerular podocytes play a key role in the pathogenesis of diabetic kidney disease (DKD). Recent studies suggest that natriuretic peptides (NPs) are podocyte protective. The beneficial effects of NPs are inhibited by the removal of NPs from the circulatio ... Full text Link to item CitePodocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis.
Journal article PLoS One · 2025 Natriuretic peptides (NPs) bind to glomerular podocytes and attenuate glomerular injury. The beneficial effects of NPs are negatively regulated by the NP clearance receptor (NPRC), which is highly expressed in podocytes. To determine if inhibiting NPRC is ... Full text Link to item CitePodocyte-Specific Knockout (KO) of the Natriuretic Peptide Clearance Receptor (NPRC) Ameliorates Glomerular Injury in a Mouse Model of Focal Segmental Glomerulosclerosis (FSGS)
Conference JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY · November 2023 Link to item CiteRecent Grants
U2C/TL1 NC KUH TRIO Administrative Core
ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME
ResearchInvestigator · Awarded by National Institutes of Health · 2023 - 2026A Novel Therapeutic Approach to Treat Focal Segmental Glomerulosclerosis (FSGS) R21
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025View All Grants
Education
Ohio State University ·
1983
M.D.